Deprescribing, the supervised withdrawal of medicines, is particularly important for frail older adults at high risk of medicines-related harm. This session will focus on optimising medicines in older adults through deprescribing, both in hospital and during transitions of care. Nashwa will share findings on clinical outcomes of hospital medication changes, including prescribing and deprescribing. She will also discuss a novel hospital stewardship program to deprescribe inappropriate polypharmacy in frail older inpatients across six NSW hospitals. Lastly, she will discuss strategies to facilitate continuity of deprescribing during transitions from hospital to home.
Learn more about the speaker
Dr Nashwa Masnoon is a Postdoctoral Research Fellow at the Laboratory of Ageing and Pharmacology, Kolling Institute, University of Sydney, and Northern Sydney Local Health District, and a Pharmacist at Royal North Shore Hospital. Her research focuses on deprescribing inappropriate polypharmacy in older inpatients and improving continuity of deprescribing during transitions of care. She completed her PhD in 2020 on identifying older adults at risk of harm from inappropriate polypharmacy. She is the lead author of the highly cited systematic review on polypharmacy definitions (Google Scholar Cites = 3292), informing key policies and reports, including citation in the WHO technical report called ‘Medication Safety in Polypharmacy’. https://doi.org/10.1186/s12877-017-0621-2
This webinar is facilitated by Frailty Nexus, the AFN’s peer-support network.
